PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
14-Oct-2020 Evelo Biosciences Completes Enrollment in Phase 1b Clinical Trial Cohort Evaluating EDP1815 in Atopic Dermatitis Evelo Biosciences
14-Oct-2020 Formedix announces expansion to meet demands for clinical trial automation Formedix
14-Oct-2020 Vitalograph Launch Powerful New In2itive e-Diary for Global Clinical Trials Vitalograph
13-Oct-2020 PHASE 2B/3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE ULCERATIVE COLITIS Ketchum
13-Oct-2020 Call for more BAME representation in COVID-19 trials will fail if long-held diversity challenges are not addressed Innovative Trials
13-Oct-2020 Kyowa Kirin Presents New Data on Response to Treatment in Cutaneous T-cell Lymphoma (CTCL) Patients Who Have Blood Involvement Kyowa
13-Oct-2020 Celltrion Initiates Post-exposure Prophylaxis Clinical Trial of an Anti-COVID-19 Monoclonal Antibody Treatment Candidate, CT-P59 Celltrion
13-Oct-2020 ProductLife Group Acquires Axpharma in Response to Accelerating Global Demand for Pharmacovigilance Support ProductLife Group
12-Oct-2020 STELARA® (ustekinumab) Five-Year Results Presented from Long-term Extension Study of Clinical Response and Remission in Patients with Moderate to Severe Crohn’s Disease Janssen Cilag ltd
12-Oct-2020 TREMFYA®▼ (guselkumab) Induces Clinical and Endoscopic Improvements in Patients with Moderately to Severely Active Crohn’s Disease based on Interim Results from Phase 2 Study Janssen Cilag ltd
12-Oct-2020 Strategic Collaboration Between Cerner and Induction Healthcare Induction Healthcare Group PLC
12-Oct-2020 Polyplus-transfection presents latest solution portfolio for gene therapy market to Alliance for Regenerative Medicine’s Meeting on the Mesa Polyplus-Transfection
12-Oct-2020 Oxular Receives Rare Paediatric Disease and Orphan-Drug Designations for Retinoblastoma Treatment Oxular
11-Oct-2020 SMi’s 3D Cell Culture conference 2021 – Speakers announced SMi Group
09-Oct-2020 North America is Largest Cancer/Tumor Profiling Market P&S Intelligence
08-Oct-2020 Iceni Diagnostics appoints BBI to produce its Covid-19/Influenza test Iceni Diagnostics
08-Oct-2020 Cytel ushers in new era of optimized clinical trial design with launch of Solara™ Cytel
07-Oct-2020 4D pharma announces topline results from Blautix(R) Phase II trial in irritable bowel syndrome (IBS) 4D pharma
07-Oct-2020 Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment Pfizer, Sangamo
07-Oct-2020 ILC Therapeutics announces ‘significant’ COVID-19 drug breakthrough ILC Therapeutics